Glycotest Announces Start of Enrollment in Its Case-Control Study of the HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma (NCT03878550).
Related News
Other posts that you should not miss.
Glycotest Announces Start of Enrollment in Its Case-Control Study of the HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma (NCT03878550). | Glycotest Diagnostics